- Home
- HXHX vs COCP Comparison
HXHX vs COCP Comparison
Compare HXHX & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- COCP
- Stock Information
- Founded
- HXHX 2003
- COCP 2006
- Country
- HXHX China
- COCP United States
- Employees
- HXHX N/A
- COCP N/A
- Industry
- HXHX Trucking Freight/Courier Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- COCP Health Care
- Exchange
- HXHX Nasdaq
- COCP Nasdaq
- Market Cap
- HXHX 16.8M
- COCP 15.4M
- IPO Year
- HXHX 2025
- COCP N/A
- Fundamental
- Price
- HXHX $0.75
- COCP $1.11
- Analyst Decision
- HXHX
- COCP Strong Buy
- Analyst Count
- HXHX 0
- COCP 1
- Target Price
- HXHX N/A
- COCP $6.00
- AVG Volume (30 Days)
- HXHX 256.3K
- COCP 182.9K
- Earning Date
- HXHX 04-30-2026
- COCP 11-14-2025
- Dividend Yield
- HXHX N/A
- COCP N/A
- EPS Growth
- HXHX N/A
- COCP N/A
- EPS
- HXHX 0.26
- COCP N/A
- Revenue
- HXHX $25,571,810.00
- COCP N/A
- Revenue This Year
- HXHX N/A
- COCP N/A
- Revenue Next Year
- HXHX N/A
- COCP N/A
- P/E Ratio
- HXHX $2.82
- COCP N/A
- Revenue Growth
- HXHX N/A
- COCP N/A
- 52 Week Low
- HXHX $0.56
- COCP $1.00
- 52 Week High
- HXHX $6.29
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- COCP 49.20
- Support Level
- HXHX N/A
- COCP $1.06
- Resistance Level
- HXHX N/A
- COCP $1.15
- Average True Range (ATR)
- HXHX 0.00
- COCP 0.07
- MACD
- HXHX 0.00
- COCP 0.01
- Stochastic Oscillator
- HXHX 0.00
- COCP 40.44
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).